Patents by Inventor HOSSEIN BORGHAEI

HOSSEIN BORGHAEI has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Antibodies to tumor endothelial marker 7R
    Patent number: 9534050
    Abstract: Antibodies that specifically bind to an epitope on the extracellular domain of TEM7R are provided. Nucleic acids encoding such antibodies and cells capable of expressing such antibodies are also provided. The antibodies may be used in methods for treating tumors and for inhibiting angiogenesis in tumors.
    Type: Grant
    Filed: October 15, 2014
    Date of Patent: January 3, 2017
    Assignee: Institute for Cancer Research
    Inventors: Hossein Borghaei, Louis M. Weiner
  • ANTIBODIES TO TUMOR ENDOTHELIAL MARKER 7R
    Publication number: 20150064190
    Abstract: Antibodies that specifically bind to an epitope on the extracellular domain of TEM7R are provided. Nucleic acids encoding such antibodies and cells capable of expressing such antibodies are also provided. The antibodies may be used in methods for treating tumors and for inhibiting angiogenesis in tumors.
    Type: Application
    Filed: October 15, 2014
    Publication date: March 5, 2015
    Inventors: Hossein Borghaei, Louis M. Weiner
  • Antibodies to tumor endothelial marker 7R
    Patent number: 8883978
    Abstract: Antibodies that specifically bind to an epitope on the extracellular domain of TEM7R are provided. Nucleic acids encoding such antibodies and cells capable of expressing such antibodies are also provided. The antibodies may be used in methods for treating tumors and for inhibiting angiogenesis in tumors.
    Type: Grant
    Filed: May 11, 2011
    Date of Patent: November 11, 2014
    Assignee: Institute for Cancer Research
    Inventors: Hossein Borghaei, Louis M. Weiner
  • ANTIBODIES TO TUMOR ENDOTHELIAL MARKER 7R
    Publication number: 20130058935
    Abstract: Antibodies that specifically bind to an epitope on the extracellular domain of TEM7R are provided. Nucleic acids encoding such antibodies and cells capable of expressing such antibodies are also provided. The antibodies may be used in methods for treating tumors and for inhibiting angiogenesis in tumors.
    Type: Application
    Filed: May 11, 2011
    Publication date: March 7, 2013
    Applicant: Fox Chase Cancer Center
    Inventors: Hossein Borghaei, Louis M. Weiner
  • METHOD FOR IMMUNE RESPONSE DETECTION
    Publication number: 20110086368
    Abstract: A method for detecting one or more immunological response factors that is expressed in response to a therapeutic treatment and/or disease using a piezoelectric microcantilever sensor (PEMS) to assess a patient's immunological response. The method involves measuring a frequency shift of the PEMS caused by binding the immunological response factors to one or more receptors on the PEMS. The method may be used to determine the effectiveness of a prescribed therapeutic treatment and/or monitor the progress of a disease.
    Type: Application
    Filed: October 7, 2010
    Publication date: April 14, 2011
    Applicant: DREXEL UNIVERSITY
    Inventors: WAN Y. SHIH, JOSEPH CAPOBIANCO, WEI-HENG SHIH, HOSSEIN BORGHAEI